The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis

BACKGROUND: Advanced triple-negative breast cancer (aTNBC) has a poor prognosis; thus, there is a need to identify novel biomarkers to guide future research and improve clinical outcomes. OBJECTIVES: We tested the prognostic ability of an emerging, complete blood count (CBC)-based inflammatory bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Provenzano, Leonardo, Lobefaro, Riccardo, Ligorio, Francesca, Zattarin, Emma, Zambelli, Luca, Sposetti, Caterina, Presti, Daniele, Montelatici, Giulia, Ficchì, Angela, Martinetti, Antonia, Arata, Alessio, Del Vecchio, Marta, Lauria Pantano, Claudia, Formisano, Barbara, Bianchi, Giulia Valeria, Capri, Giuseppe, de Braud, Filippo, Vernieri, Claudio, Fucà, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102956/
https://www.ncbi.nlm.nih.gov/pubmed/37063779
http://dx.doi.org/10.1177/17588359231165978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102956/
https://www.ncbi.nlm.nih.gov/pubmed/37063779
http://dx.doi.org/10.1177/17588359231165978

Ejemplares similares